CRISPR/Cas9 screen in human iPSC‐derived cortical neurons identifies NEK6 as a novel disease modifier of <i>C9orf72</i> poly(PR) toxicity
Wenting Guo(VIB-KU Leuven Center for Brain & Disease Research), Catherine M. Verfaillie(University of Minnesota), Philip Van Damme(VIB-KU Leuven Center for Brain & Disease Research), Tine Tricot(KU Leuven), Sriram Balusu(VIB-KU Leuven Center for Brain & Disease Research), Bart De Strooper(Allen Institute for Brain Science), Dietmar Rudolf Thal(Allen Institute for Brain Science), Madhavsai Gajjar(Rega Institute for Medical Research), Arun Kumar Tharkeshwar(IMEC), Nicole Hersmus(VIB-KU Leuven Center for Brain & Disease Research), Francis Impens(Ghent University Hospital), Pieter Vanden Berghe(KU Leuven), Julien Couthouis(Stanford University), Rekin’s Janky(KU Leuven), Siddharthan Chandran(MRC Centre for Regenerative Medicine), Maarten Jacquemyn(Rega Institute for Medical Research), Ritchie Ho(Cedars-Sinai Medical Center), Muralidhar L. Hegde(Houston Methodist), Ludo Van Den Bosch(Allen Institute for Brain Science), Rik Vandenberghe(Allen Institute for Brain Science), Laura Fumagalli(VIB-KU Leuven Center for Brain & Disease Research), Dirk Daelemans(Rega Institute for Medical Research), Elke Braems(VIB-KU Leuven Center for Brain & Disease Research), Pegah Masrori(VIB-KU Leuven Center for Brain & Disease Research), Evelien Van Schoor(VIB-KU Leuven Center for Brain & Disease Research), Haibo Wang(Shandong University), Rodrigo Madeiro da Costa(D’Or Institute for Research and Education), Karan Ahuja(Rega Institute for Medical Research), Yannan Fan(Rega Institute for Medical Research), Matthieu Moisse(VIB-KU Leuven Center for Cancer Biology)
Cited by 26
Related Papers
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
|Neurology|2002|3.5k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
|Journal of Neuropathology & Experimental Neurology|2011|2.3k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k